Transcranial Magnetic Stimulation - Pharma

Relevant Publications

Public Perceptions of Neurotechnologies Used to Target Mood, Memory, and Motor Symptoms.

Issue Release: 2024

Neuromodulatory transcranial magnetic stimulation (TMS) changes functional connectivity proportional to the electric-field induced by the TMS pulse.

Issue Release: 2024

Efficacy of Cerebellar Transcranial Magnetic Stimulation in Treating Essential Tremor: A Randomized, Sham-Controlled Trial.

Issue Release: 2024

New and Evolving Treatments for Neurologic Dysphagia.

Issue Release: 2024

Reduced TMS-evoked EEG oscillatory activity in cortical motor regions in patients with post-COVID fatigue.

Issue Release: 2024

Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.

Issue Release: 2024

The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models.

Issue Release: 2024

Transcranial magnetic stimulation to improve aphasia after right hemispheric stroke: A single case experimental design.

Issue Release: 2024

The consolidation of newly learned movements depends upon somatosensory cortex in humans.

Issue Release: 2024

The excitability of ipsilateral motor evoked potentials is not task-specific and spatially distinct from the contralateral motor hotspot.

Issue Release: 2024

Electric field envelope focality in superficial brain areas with linear alignment montage in temporal interference stimulation.

Issue Release: 2024

Sensorimotor integration in chronic low back pain.

Issue Release: 2024

Effectiveness of repetitive transcranial magnetic stimulation for insomnia disorder on fear memory extinction: study protocol for a randomised controlled trial.

Issue Release: 2024

No add-on therapeutic benefit of at-home anodal tDCS of the primary motor cortex to mindfulness meditation in patients with fibromyalgia.

Issue Release: 2024

Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis.

Issue Release: 2024

Non-invasive neurostimulation to improve sleep quality and depressive symptoms in patients with major depressive disorder: A meta-analysis of randomized controlled trials.

Issue Release: 2024

Early symptom improvement and other clinical predictors of response to repetitive transcranial magnetic stimulation for depression.

Issue Release: 2024

A simulation study of transcranial magnetoacoustic stimulation of the basal ganglia thalamic neural network to improve pathological beta oscillations in Parkinson\'s disease.

Issue Release: 2024

Sleep in juvenile myoclonic epilepsy: A systematic review.

Issue Release: 2024

Changes in corticospinal excitability during motor imagery by physical practice of a force production task: Effect of the rate of force development during practice.

Issue Release: 2024

What is Regulatory Approval?

What Are the Challenges in Managing Chronic Conditions?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

What Challenges Exist in Patient Education?

What Are Clinical Trials?

Why is Generic Competition Important?

Why is the Management of Chronic Conditions Important?

Why is Regulatory Approval Important?

What is Pharma?

What is Generic Competition?

Partnered Content Networks

Relevant Topics